A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals

Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
10/2004
10/21/2004	WO2004090532A1 Method of determining xenograft responses
10/21/2004	WO2004090126A2 Phosphodiesterase 10a7 isoforms and methods of use
10/21/2004	WO2004089072A2 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene
10/21/2004	WO2004089071A1 Non-human mammals and animal cells containing a mutated alpha2/delta gene
10/21/2004	WO2004042023B1 Stem cell libraries
10/21/2004	WO2003104431A3 Transgenic mammals expressing polyglutamine
10/21/2004	WO1995027066A9 Dna encoding ubiquitin conjugating enzymes
10/21/2004	US20040210954 Using homologous recombination to insert/transfer heterologous genomes into birds; tissue engineering and heterologous protein expression
10/21/2004	US20040210953 Lysozyme transgenic ungulates
10/21/2004	US20040210952 Transgenic animals
10/21/2004	US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS)
10/21/2004	US20040209833 Transgenic fish germline expression driven by liver fatty acid binding (L-FABP) gene promoter and applications thereof
10/21/2004	US20040209342 Comprises nucleotide sequences coding hydrolase for use in identifying modulators for treatment of diabetes and inflammatory diseases
10/21/2004	US20040209313 T2R receptor binding assays that identify potential bitter taste modulatory compounds
10/21/2004	US20040209308 Methods of assaying receptor activity and constructs useful in such methods
10/21/2004	US20040209279 Comprises regulatory nucleotide sequences for generating animal model for liver disorders
10/21/2004	US20040209274 Constructs for Gene Expression Analysis
10/21/2004	US20040209268 Process for constructing mutant
10/21/2004	US20040208881 B1k chain of laminin and methods of use
10/21/2004	US20040208857 Producing a donor-specific immunotolerance against transplanted tissue by administering embryonic stem cell-like cell lines (ECL) obtained from blastocysts and are transfected with genetic material of the donor, which codes for the major histocompatibility complex (MHC) haplotypes
10/21/2004	US20040208846 Mini-Ad vector for immunization
10/21/2004	CA2521614A1 Method of determining xenograft responses
10/21/2004	CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them
10/21/2004	CA2520866A1 Phosphodiesterase 2a and methods of use
10/21/2004	CA2520803A1 Phosphodiesterase 10a7 isoforms and methods of use
10/20/2004	EP1468293A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases
10/20/2004	EP1468091A2 Transmembrane protein
10/20/2004	EP1468019A2 Secreted protein
10/20/2004	EP1468018A2 Leptin proteins
10/20/2004	EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS
10/20/2004	EP1467616A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
10/20/2004	EP1294236A4 Animal food and method
10/20/2004	EP1280465A4 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
10/20/2004	CN1538853A T cell regulatory genes and methods of use thereof
10/20/2004	CN1171528C Method for bredding new strain chicken with yellow (white)tibiala and complete set application
10/14/2004	WO2004087898A1 Method of transplanting foreign cell into mammalian embryo
10/14/2004	WO2004087888A2 Neurotransmitter signaling can regulate life span in c. elegans
10/14/2004	WO2004087751A1 Dystrophin-related protein (drop1), a marker for carcinomas
10/14/2004	WO2004087744A2 Composition and method for nerve regeneration
10/14/2004	WO2004087536A2 Conditioning of useful insects or mites, method for production thereof and use thereof in the biological eradication of plant ravagers
10/14/2004	WO2004086858A1 Model animal of normal-pressure glaucoma
10/14/2004	WO2004031233A3 Novel chemokine-like polypeptides
10/14/2004	WO2004029621A3 Tcell mediator/modulator assay based upon tcell restricted transgenic mouse
10/14/2004	WO2003104811A3 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases
10/14/2004	WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them
10/14/2004	WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
10/14/2004	US20040205838 Use of Flp recombinase in mice
10/14/2004	US20040205837 Transgenic mouse over-expressing calreticulin (CRT) in vascular smooth muscle cells
10/14/2004	US20040205836 Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss
10/14/2004	US20040205835 Jak kinases and regulation of cytokine signal transduction
10/14/2004	US20040205834 System for inducible expression in eukaryotic cells
10/14/2004	US20040205832 Transgenically produced decorin
10/14/2004	US20040205831 Transgenic SHIP2 animals and in vivo screening methods
10/14/2004	US20040204361 Kdel receptor inhibitors
10/14/2004	US20040204338 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
10/14/2004	US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
10/14/2004	US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis
10/14/2004	US20040203117 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells
10/14/2004	US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents
10/14/2004	US20040203087 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout
10/14/2004	US20040203021 functional to a yeast site-specific flippase recombinase (FLP); for occurring a local and imprecise transposition; for drug screening; genetic engineering
10/14/2004	US20040200420 Method of producing avian eggs and birds of germ-free status
10/13/2004	EP1466618A1 Treatment for diabetes
10/13/2004	EP1465994A2 Rabbit nuclear cloning method and uses thereof
10/13/2004	EP1465993A2 Inducible transposition in transgenic organism using transposon vector
10/13/2004	EP1465986A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof
10/13/2004	EP1465981A2 Methods and compositions for generating a genetically modified animal using lentiviral vectors
10/13/2004	EP1465481A1 Knockout swine and methods for making the same
10/13/2004	CN1537167A Von willebrand factor (VWF)-cleaving enzyme
10/13/2004	CN1537166A New elongase gene and production of Delta 9-polyunsaturated fatty acids
10/13/2004	CN1535728A Drug composition for curing disease produced from IL-6
10/13/2004	CN1170511C Compositions for freezing dog sperm and method for employing the frozen dog sperm
10/13/2004	CN1170474C Transgenic silkworm screening method
10/12/2004	US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis
10/12/2004	US6803211 Cancer therapy
10/12/2004	US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same
10/12/2004	CA2254435C Foldable nest surround
10/07/2004	WO2004085645A1 Rna interference in fish
10/07/2004	WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
10/07/2004	WO2004084808A2 Animal with surgically modified gastrointestinal tract and method for study of weight reduction
10/07/2004	WO2004084711A2 Methods of detecting neurological disorders
10/07/2004	WO2004064714A3 Animal model for obesity independently of insulin resistance
10/07/2004	WO2004042035A3 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders
10/07/2004	WO2004033640A3 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter
10/07/2004	WO2002092000A3 Hbm variants that modulate bone mass and lipid levels
10/07/2004	US20040199934 Transgenic rodents as animal moldels for modulation of b1 bradykinin receptor protein
10/07/2004	US20040197910 Gene regulation in transgenic animals using a transposon-based vector
10/07/2004	US20040197859 useful for treatment of migraine headaches/prophylaxis, menopausal hot flashes, chronic tension type headache, cluster headache, neurogenic or chronic inflammation, gastrointestinal disorders, type 2 diabetes and cardiovascular disorders
10/07/2004	US20040197798 Using alteration in phosphorylation to detect, diagnose, prevent and prognose cell proliferative disorders
10/07/2004	US20040197786 Method of examining steroid resnponsiveness
10/07/2004	US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins
10/06/2004	EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases
10/06/2004	EP1464651A1 Dystrophin-related protein (Drop1), a marker for carcinomas
10/06/2004	EP1463820A1 Method of screening compounds
10/06/2004	EP1463802A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos
10/06/2004	EP1463758A2 Mammal prolactin variants
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463754A2 Cystine-knot fold protein
10/06/2004	EP1463409A2 Gene delivery system and methods of use
10/06/2004	EP1463405A2 Hair removal and animal husbandry method

1 ... 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 ... 341